AAAAAA

   
Results: 1-10 |
Results: 10
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: A randomized phase II trial in small-cell lung cancer patients
Authors: Woll, PJ Thatcher, N Lomax, L Hodgetts, J Lee, SM Burt, PA Stout, R Simms, T Davies, R Pettengell, R
Citation: Pj. Woll et al., Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: A randomized phase II trial in small-cell lung cancer patients, J CL ONCOL, 19(3), 2001, pp. 712-719
A phase I trial of amsalog (Cl-921) administered by intravenous infusion using a 5-day schedule
Authors: Fyfe, D Price, C Langley, RE Pagonis, C Houghton, J Osborne, L Woll, PJ Gardner, C Baguley, BC Carmichael, J
Citation: D. Fyfe et al., A phase I trial of amsalog (Cl-921) administered by intravenous infusion using a 5-day schedule, CANC CHEMOT, 47(4), 2001, pp. 333-337
Use of RT-PCR to detect co-expression of neuropeptides and their receptorsin lung cancer
Authors: Ocejo-Garcia, M Ahmed, SI Coulson, JM Woll, PJ
Citation: M. Ocejo-garcia et al., Use of RT-PCR to detect co-expression of neuropeptides and their receptorsin lung cancer, LUNG CANC, 33(1), 2001, pp. 1-9
Lung cancer as the presenting feature of AIDS
Authors: White, JD Bowman, CA Woll, PJ
Citation: Jd. White et al., Lung cancer as the presenting feature of AIDS, LUNG CANC, 33(1), 2001, pp. 81-87
Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium
Authors: Ahmed, SI Thompson, J Coulson, JM Woll, PJ
Citation: Si. Ahmed et al., Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium, AM J RESP C, 22(4), 2000, pp. 422-431
A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and a useful clinical marker
Authors: Coulson, JM Edgson, JL Woll, PJ Quinn, JP
Citation: Jm. Coulson et al., A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and a useful clinical marker, CANCER RES, 60(7), 2000, pp. 1840-1844
Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group
Authors: Woll, PJ Judson, I Lee, SM Rodenhuis, S Nielsen, OS Buesa, JM Lorigan, PC Leyvraz, S Hermans, C van Glabbeke, M Verweij, J
Citation: Pj. Woll et al., Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group, EUR J CANC, 35(3), 1999, pp. 410-412
E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer
Authors: Coulson, JM Fiskerstrand, CE Woll, PJ Quinn, JP
Citation: Jm. Coulson et al., E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer, BIOCHEM J, 344, 1999, pp. 961-970
Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer
Authors: Coulson, JM Fiskerstrand, CE Woll, PJ Quinn, JP
Citation: Jm. Coulson et al., Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer, CANCER RES, 59(20), 1999, pp. 5123-5127
Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
Authors: Coulson, JM Stanley, J Woll, PJ
Citation: Jm. Coulson et al., Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer, BR J CANC, 80(12), 1999, pp. 1935-1944
Risultati: 1-10 |